Salivary gland neoplasms are a morphologically heterogenous group of lesions that are
often diagnostically challenging. In recent years, considerable progress in salivary gland …

Salivary gland carcinomas (SGC) account for less than 5% of head and neck malignant
neoplasms, further subcategorized in over 20 histological subtypes. For the most part …

Background Systemic therapy options for salivary cancers are limited. MyPathway
(NCT02091141), a phase IIa study, evaluates targeted therapies in non-indicated tumor …

Salivary gland neoplasms are an uncommon and widely heterogeneous group of tumors. In
recent years, there has been considerable progress in efforts to reveal the molecular …

No effective systemic treatment is available for patients with unresectable, recurrent, or
metastatic mucoepidermoid carcinoma (MEC), the most common salivary gland malignancy …

Background Relapsed/metastatic salivary gland carcinomas (SGCs) have a wide diversity of
histologic subtypes associated with variable clinical aggressiveness and response to local …

Primary tracheal tumors are rare, constituting approximately 0.1–0.4% of malignant
diseases. Squamous cell carcinoma (SCC) and adenoid cystic carcinoma (ACC) account for …

Pulmonary mucoepidermoid carcinoma (PMEC) is the most common malignant salivary
gland tumor in the lungs and accounts for 0.1‐0.2% of all lung malignancies in adults. It has …

Mucoepidermoid carcinoma (MEC) of the breast is an extremely rare salivary gland‐type
tumor characterized by epidermoid, basaloid, intermediate, and/or mucinous cells arranged …

Purpose: Mucoepidermoid carcinoma (MEC) is a poorly understood salivary gland
malignancy with limited therapeutic options. Cancer stem cells (CSC) are considered drivers …